Daily FNArena News - FYI
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure ChestPrevious Stories
RESEARCH: Interview CEO ReTech Technology
Oct 30 2019
Pitt Street Research interviewed Grace Lin, CEO of ReTech Technology.
Follow The Money On These Two Companies
Oct 23 2019
Peter Switzer of the Switzer Report selects two stocks which suggest the trend is your friend.
RESEARCH: Interview Real Energy MD Scott Brown
Oct 22 2019
Pitt Street Research analyst Stuart Roberts speaks with Scott Brown, MD of Real Energy
Ten Stocks That Will Benefit From A Trade Deal
Oct 15 2019
Peter Switzer of the Switzer Report suggests ten stocks (including ETFs) that he sees as trade deal beneficiaries.
RESEARCH: ReTech Technology, Fast-Growing EdTech Play
Oct 11 2019
Pitt Street Research initiates coverage of China-based eLearning SaaS company, Retech Technology.
Two Ways To Play The Pain Medication Game
Oct 03 2019
The New Criterion’s Tim Boreham notes massive legal settlements in the US have highlighted the scourge of opioid abuse, but Australian producer Palla Pharma is confident the drug class will remain the world’s foremost pain medication.
RESEARCH: MyFiziq, Expansion Through Partnerships
Oct 02 2019
Pitt Street Research has revised its valuation range for MyFiziq.
Dump Gold, Buy Stocks
Oct 01 2019
Peter Switzer of the Switzer Super Report suggests gold’s run is over and its time to back the stock market.
RESEARCH: Energy Technologies, Emerging Cable And Wire Player
Oct 01 2019
Pitt Street Research has initiated coverage of Sydney-based Energy Technologies, an emerging cable and wire player.
RESEARCH: Innovative Medical Device Company, Imagion Biosystems
Sep 27 2019
Pitt Street Research explains why Imagion Biosystems shares look undervalued.
